Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NOS3 | P29474 | 2/20 | 0.44 |
| ▸ | NOS1 | P29475 | 2/20 | 0.44 |
| ▸ | NOS2 | P35228 | 2/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5833496 | 0.86 | SIGMAR1 (0.44) | KDM4ESMN1; SMN2RAB9AGAAALDH1A1 | |
| SCHEMBL242519 | 0.86 | KDM4E (0.53) | KDM4ESMN1; SMN2RAB9AGAAALDH1A1 | |
| SCHEMBL8166694 | 0.86 | KDM4E (0.53) | KDM4ESMN1; SMN2RAB9AGAAALDH1A1 | |
| Hydrochloric Acid SCHEMBL3291945 | 0.86 | SIGMAR1 (0.44) | KDM4ESMN1; SMN2RAB9AGAAALDH1A1 | |
| Hydrochloric Acid SCHEMBL3291942 | 0.86 | SIGMAR1 (0.44) | KDM4ESMN1; SMN2RAB9AGAAALDH1A1 | |
| SCHEMBL242518 | 0.86 | KDM4E (0.53) | KDM4ESMN1; SMN2RAB9AGAAALDH1A1 | |
| SCHEMBL30635011 | 0.85 | SIGMAR1 (0.46) | KDM4ESMN1; SMN2RAB9AGAAMEN1 | |
| SCHEMBL4618223 | 0.85 | SIGMAR1 (0.46) | KDM4ESMN1; SMN2RAB9AGAAMEN1 | |
| SCHEMBL4618229 | 0.85 | SIGMAR1 (0.46) | KDM4ESMN1; SMN2RAB9AGAAMEN1 | |
| SCHEMBL8167553 | 0.84 | KDM4E (0.51) | KDM4ESMN1; SMN2RAB9AGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11746167-B2 | Process for the preparation of polyisoprene with a mainly alternating cis-1,4- alt-3,4 structure in the presence of a catalytic system comprising a pyridyl iron complex | VERSALIS S.P.A. (IT) | 2023-09-05 | — | — | US | disclosed |
| US-11746167-B2 | Process for the preparation of polyisoprene with a mainly alternating cis-1,4- alt-3,4 structure in the presence of a catalytic system comprising a pyridyl iron complex | VERSALIS S.P.A. (IT) | 2023-09-05 | — | — | US | disclosed |
| US-10954326-B2 | Process for the preparation of syndiotactic 1,2-polybutadiene in the presence of a catalytic system comprising a pyridyl iron complex | VERSALIS S.P.A. (IT) | 2021-03-23 | — | — | US | disclosed |
| EP-3529289-B1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | VERSALIS SPA (IT) | 2020-12-02 | — | — | EP | disclosed |
| US-20200369805-A1 | PROCESS FOR THE PREPARATION OF POLYISOPRENE WITH A MAINLY ALTERNATING CIS-1,4- ALT-3,4 STRUCTURE IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON COMPLEX | VERSALIS S.P.A. (IT) | 2020-11-26 | — | — | US | disclosed |
| US-10793653-B2 | Process for preparing conjugated diene (co)polymers in the presence of a catalytic system comprising a pyridyl iron (III) complex | VERSALIS S.P.A. (IT) | 2020-10-06 | — | — | US | disclosed |
| EP-3529285-B1 | PROCESS FOR THE PREPARATION OF SYNDIOTACTIC 1,2-POLYBUTADIENE IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON COMPLEX | VERSALIS SPA (IT) | 2020-08-05 | — | — | EP | disclosed |
| EP-3194409-B1 | PYRIDINE COMPLEX OF ZIRCONIUM, CATALYTIC SYSTEM COMPRISING SAID PYRIDINE COMPLEX OF ZIRCONIUM AND PROCESS OF (CO)POLYMERIZATION OF CONJUGATED DIENES | VERSALIS SPA (IT) | 2019-09-11 | — | — | EP | disclosed |
| US-20190270832-A1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | VERSALIS S.P.A. (IT) | 2019-09-05 | — | — | US | disclosed |
| WO-2018073795-A1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | VERSALIS S.P.A. (IT) | 2018-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10954326-B2 | Process for the preparation of syndiotactic 1,2-polybutadiene in the presence of a catalytic system comprising a pyridyl iron complex | AOC3, C9, SCO2 | KDM4E 2179/4885SMN1; SMN2 1407/4885RAB9A 4348/4885 |
| US-20190270832-A1 | PROCESS FOR PREPARING CONJUGATED DIENE (CO)POLYMERS IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON (III) COMPLEX | AOC3, C5, AOC2 | KDM4E 4296/4885SMN1; SMN2 3007/4885RAB9A 653/4885 |
| US-10793653-B2 | Process for preparing conjugated diene (co)polymers in the presence of a catalytic system comprising a pyridyl iron (III) complex | AOC3, C5, AOC2 | KDM4E 4296/4885SMN1; SMN2 3007/4885RAB9A 653/4885 |
| US-11746167-B2 | Process for the preparation of polyisoprene with a mainly alternating cis-1,4- alt-3,4 structure in the presence of a catalytic system comprising a pyridyl iron complex | AOC3, AOC2, C5 | KDM4E 4169/4885SMN1; SMN2 2787/4885RAB9A 771/4885 |
| US-20200369805-A1 | PROCESS FOR THE PREPARATION OF POLYISOPRENE WITH A MAINLY ALTERNATING CIS-1,4- ALT-3,4 STRUCTURE IN THE PRESENCE OF A CATALYTIC SYSTEM COMPRISING A PYRIDYL IRON COMPLEX | AOC3, AOC2, C5 | KDM4E 4169/4885SMN1; SMN2 2787/4885RAB9A 771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.